Coverart for item
The Resource Drugs during pregnancy and lactation : treatment options and risk assessment, edited by Christof Schaefer, Paul Peters, and Richard K. Miller

Drugs during pregnancy and lactation : treatment options and risk assessment, edited by Christof Schaefer, Paul Peters, and Richard K. Miller

Label
Drugs during pregnancy and lactation : treatment options and risk assessment
Title
Drugs during pregnancy and lactation
Title remainder
treatment options and risk assessment
Statement of responsibility
edited by Christof Schaefer, Paul Peters, and Richard K. Miller
Creator
Contributor
Editor
Subject
Genre
Language
  • eng
  • ger
  • eng
Summary
Drugs During Pregnancy and Lactation, 3rd Edition is a quick and reliable reference for all those working in disciplines related to fertility, pregnancy, lactation, child health and human genetics who prescribe or deliver medicinal products, and to those who evaluate health and safety risks. Each chapter contains twofold information regarding drugs that are appropriate for prescription during pregnancy and an assessment of the risk of a drug when exposure during pregnancy has already occurred. Thoroughly updated with current regulations, references to the latest pharmacological data, and new
Member of
Cataloging source
UKMGB
http://bibfra.me/vocab/lite/collectionName
  • Arzneimittel in Schwangerschaft und Stillzeit
  • Arzneimittel in Schwangerschaft und Stillzeit
Dewey number
618.32
Illustrations
illustrations
Index
index present
Language note
Translated from German
LC call number
RG627.6.D79
Literary form
non fiction
Nature of contents
  • dictionaries
  • bibliography
  • handbooks
NLM call number
WQ 200.1
http://library.link/vocab/relatedWorkOrContributorDate
1946-
http://library.link/vocab/relatedWorkOrContributorName
  • Schaefer, Christof
  • Peters, P. W. J.
  • Miller, Richard K.
Series statement
ClinicalKey
http://library.link/vocab/subjectName
  • Pregnant women
  • Pregnant women
  • Obstetrical pharmacology
  • Fetus
  • Newborn infants
  • Drug Therapy
  • Contraindications
  • Drug-Related Side Effects and Adverse Reactions
  • Fetus
  • Infant, Newborn
  • Lactation
  • Pregnancy
  • MEDICAL
  • Fetus
  • Newborn infants
  • Obstetrical pharmacology
  • Pregnant women
  • Pregnant women
Label
Drugs during pregnancy and lactation : treatment options and risk assessment, edited by Christof Schaefer, Paul Peters, and Richard K. Miller
Instantiates
Publication
Copyright
Note
  • Previous edition: 2007
  • Translation of: Arzneimittel in Schwangerschaft und Stillzeit / Christof Schaefer ... (Hrsg.). Mit Beitr. von Stephanie Padberg ... 8., vollst. überarb. Aufl. 2012
Bibliography note
Includes bibliographical references and index
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
  • Cover; Drugs During Pregnancy and Lactation; Copyright; Contents; List of Contributors; Preface; Disclaimer; 1 -- General commentary on drug therapy and drug risks in pregnancy; 1.1 Introduction; 1.2 Development and health; 1.3 Reproductive stages; 1.4 Reproductive and developmental toxicology; 1.5 Basic principles of drug-induced reproductive and developmental toxicology; 1.6 Effects and manifestations; 1.7 Pharmacokinetics of drugs in pregnancy; 1.8 Mechanisms of developmental toxic agents; 1.9 Causes of developmental disorders; 1.10 Embryo/fetotoxic risk assessment and plausibility
  • 1.11 Classification of drugs used in pregnancy1.12 Paternal use of medicinal products; 1.13 Communicating the risk of drug use in pregnancy; 1.14 Risk communication prior to pharmacotherapeutic choice; 1.15 Risk communication regarding the safety of drugs already used in pregnancy; 1.16 Teratology information centers; References; 2 -- Specific drug therapiesduring pregnancy; 2.1 -- Analgesics, non-steroidal anti-inflammatory drugs (NSAIDs), muscle relaxants, and antigout medications; 2.1.1 Paracetamol (acetaminophen); 2.1.2 Acetylsalicylic acid; 2.1.3 Pyrazolone compounds and phenylbutazone
  • 2.4.9 Other antiemeticsSummary; References; 2.5 -- Gastro-intestinal medications, hypolipidemic agents and spasmolytics; 2.5.1 Antacids; 2.5.2 Sucralfate and pirenzepine; 2.5.3 H2 receptor antagonists; 2.5.4 Proton pump inhibitors; 2.5.5 Bismuth salts; 2.5.6 Helicobacter pylori therapy; 2.5.7 Digestives and carminatives; 2.5.8 Atropine and other anticholinergic spasmolytics; 2.5.9 Cholinergics; 2.5.10 Constipation during pregnancy; 2.5.11 Antidiarrheal agents; 2.5.12 Medications for inflammatory bowel disease; 2.5.13 Chenodeoxycholic acid and ursodeoxycholic acid; 2.5.14 Lipid lowering agents
Control code
892869035
Edition
Third edition.
Extent
1 online resource
Form of item
online
Isbn
9780124079014
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Other physical details
illustrations
http://library.link/vocab/ext/overdrive/overdriveId
425b2d77-08ae-4574-b033-1bdecf099469
Specific material designation
remote
System control number
(OCoLC)892869035
Label
Drugs during pregnancy and lactation : treatment options and risk assessment, edited by Christof Schaefer, Paul Peters, and Richard K. Miller
Publication
Copyright
Note
  • Previous edition: 2007
  • Translation of: Arzneimittel in Schwangerschaft und Stillzeit / Christof Schaefer ... (Hrsg.). Mit Beitr. von Stephanie Padberg ... 8., vollst. überarb. Aufl. 2012
Bibliography note
Includes bibliographical references and index
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
  • Cover; Drugs During Pregnancy and Lactation; Copyright; Contents; List of Contributors; Preface; Disclaimer; 1 -- General commentary on drug therapy and drug risks in pregnancy; 1.1 Introduction; 1.2 Development and health; 1.3 Reproductive stages; 1.4 Reproductive and developmental toxicology; 1.5 Basic principles of drug-induced reproductive and developmental toxicology; 1.6 Effects and manifestations; 1.7 Pharmacokinetics of drugs in pregnancy; 1.8 Mechanisms of developmental toxic agents; 1.9 Causes of developmental disorders; 1.10 Embryo/fetotoxic risk assessment and plausibility
  • 1.11 Classification of drugs used in pregnancy1.12 Paternal use of medicinal products; 1.13 Communicating the risk of drug use in pregnancy; 1.14 Risk communication prior to pharmacotherapeutic choice; 1.15 Risk communication regarding the safety of drugs already used in pregnancy; 1.16 Teratology information centers; References; 2 -- Specific drug therapiesduring pregnancy; 2.1 -- Analgesics, non-steroidal anti-inflammatory drugs (NSAIDs), muscle relaxants, and antigout medications; 2.1.1 Paracetamol (acetaminophen); 2.1.2 Acetylsalicylic acid; 2.1.3 Pyrazolone compounds and phenylbutazone
  • 2.4.9 Other antiemeticsSummary; References; 2.5 -- Gastro-intestinal medications, hypolipidemic agents and spasmolytics; 2.5.1 Antacids; 2.5.2 Sucralfate and pirenzepine; 2.5.3 H2 receptor antagonists; 2.5.4 Proton pump inhibitors; 2.5.5 Bismuth salts; 2.5.6 Helicobacter pylori therapy; 2.5.7 Digestives and carminatives; 2.5.8 Atropine and other anticholinergic spasmolytics; 2.5.9 Cholinergics; 2.5.10 Constipation during pregnancy; 2.5.11 Antidiarrheal agents; 2.5.12 Medications for inflammatory bowel disease; 2.5.13 Chenodeoxycholic acid and ursodeoxycholic acid; 2.5.14 Lipid lowering agents
Control code
892869035
Edition
Third edition.
Extent
1 online resource
Form of item
online
Isbn
9780124079014
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Other physical details
illustrations
http://library.link/vocab/ext/overdrive/overdriveId
425b2d77-08ae-4574-b033-1bdecf099469
Specific material designation
remote
System control number
(OCoLC)892869035

Library Locations

    • Curtis Laws Wilson LibraryBorrow it
      400 West 14th Street, Rolla, MO, 65409, US
      37.955220 -91.772210
Processing Feedback ...